BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22416831)

  • 21. Alzheimer's disease genetics current status and future perspectives.
    Bertram L
    Int Rev Neurobiol; 2009; 84():167-84. PubMed ID: 19501718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's (AD).
    J Pract Nurs; 2009; 59(2):5-7. PubMed ID: 19718998
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genome-wide association study of Alzheimer's disease using random forests and enrichment analysis.
    Zou L; Huang Q; Li A; Wang M
    Sci China Life Sci; 2012 Jul; 55(7):618-25. PubMed ID: 22864836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic risk factor of Alzheimer's disease].
    Kuwano R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):908-11. PubMed ID: 18210832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population.
    Antúnez C; Boada M; López-Arrieta J; Ramirez-Lorca R; Hernández I; Marín J; Martínez-Lage P; González-Pérez A; Jorge Galan J; Gayán J; Real LM; Ruiz A
    J Alzheimers Dis; 2009; 18(4):751-4. PubMed ID: 19749441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell adhesion molecules contribute to Alzheimer's disease: multiple pathway analyses of two genome-wide association studies.
    Liu G; Jiang Y; Wang P; Feng R; Jiang N; Chen X; Song H; Chen Z
    J Neurochem; 2012 Jan; 120(1):190-8. PubMed ID: 22017384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
    Beyer K; Lao JI; Latorre P; Ariza A
    Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Importance of molecular diagnostics in Alzheimer dementia. A case report].
    Honneth J; Nehen HG; Haseke J
    Z Gerontol Geriatr; 2010 Jun; 43(3):177-9. PubMed ID: 20354860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and epigenetics of Alzheimer's disease.
    Alagiakrishnan K; Gill SS; Fagarasanu A
    Postgrad Med J; 2012 Sep; 88(1043):522-9. PubMed ID: 22543304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.
    Lambert JC; Grenier-Boley B; Chouraki V; Heath S; Zelenika D; Fievet N; Hannequin D; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Amouyel P
    J Alzheimers Dis; 2010; 20(4):1107-18. PubMed ID: 20413860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between NOS3 gene G894T polymorphism and late-onset Alzheimer disease in a sample from Iran.
    Azizi Z; Noroozian M; Kaini-Moghaddam Z; Majlessi N
    Alzheimer Dis Assoc Disord; 2010; 24(2):204-8. PubMed ID: 20505439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
    Caraci F; Bosco P; Signorelli M; Spada RS; Cosentino FI; Toscano G; Bonforte C; Muratore S; Prestianni G; Panerai S; Giambirtone MC; Gulotta E; Romano C; Salluzzo MG; Nicoletti F; Copani A; Drago F; Aguglia E; Ferri R
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):281-9. PubMed ID: 21924590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population.
    Komatsu M; Shibata N; Kuerban B; Ohnuma T; Baba H; Arai H
    Psychogeriatrics; 2011 Mar; 11(1):14-8. PubMed ID: 21447104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
    Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide analysis of genetic predisposition to Alzheimer's disease and related sex disparities.
    Nazarian A; Yashin AI; Kulminski AM
    Alzheimers Res Ther; 2019 Jan; 11(1):5. PubMed ID: 30636644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NALP1/NLRP1 genetic variants are associated with Alzheimer disease.
    Pontillo A; Catamo E; Arosio B; Mari D; Crovella S
    Alzheimer Dis Assoc Disord; 2012; 26(3):277-81. PubMed ID: 21946017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.